Perimenopause is the transitional period before menopause, typically starting in the mid-to-late 40s and lasting several years, in which ovarian hormone production becomes irregular — estrogen fluctuates rather than falls steadily, which is why symptoms come and go. The average duration is about four years, per the North American Menopause Society's (now the Menopause Society) published information, and it ends officially twelve months after the final menstrual period. Symptoms are real, common, and treatable — none of it is imagined.
One Women's Health publishes information, not medical advice. Symptoms and treatment decisions belong with your clinician, and this article explains processes rather than recommending any therapy.
When does perimenopause usually start?
Most commonly between 45 and 47, though a normal range spans the late 30s to early 50s, per the Menopause Society's patient information. Smoking shifts the timeline earlier — a documented association in the research literature. The start is gradual and often unrecognized: cycle changes show up years before hot flashes, which is why many people spend the early transition not knowing it has begun. Pregnancy remains possible until menopause is confirmed, a point every guideline body makes because contraception questions run through this period.
What is happening with the hormones?
The mechanics explain the experience. The ovaries' remaining eggs decline in number and responsiveness, and the brain's signaling hormones — FSH among them — rise to compensate, per endocrinology references maintained by the National Institutes of Health. Estrogen does not decline evenly; it swings high in some cycles and low in others. A high-estrogen cycle can feel like premenstrual symptoms at their worst; a low one can bring hot flashes and poor sleep. This fluctuation, not a simple shortage, is what distinguishes perimenopause from menopause itself.
Which changes are typical?
The documented picture, per the Menopause Society and NIH information, includes:
- Cycle changes — shorter, longer, heavier, lighter, or skipped, often the first sign
- Hot flashes and night sweats, affecting a majority at some point
- Sleep disruption, frequently from night sweats but also independently
- Mood changes, including worsened premenstrual symptoms
- Vaginal dryness and discomfort, usually later in the transition
- Brain-fog descriptions — the evidence here is real but modest, and researchers including authors of 2023 reviews in Menopause note it warrants more study
Every list like this has exceptions in both directions: some people notice little, others notice a great deal, and both are normal.
Why do symptoms come in waves?
Because the hormones do. A stretch of months can pass feeling unchanged, followed by a month of disrupted sleep and heavy periods, followed by calm again — the pattern the fluctuation model predicts. This unpredictability is itself a documented source of distress; knowing the waves are typical, per the Menopause Society's materials, is part of what helps. Cycle tracking through this period, even loosely, gives both you and a clinician a picture no memory can reconstruct.
What can actually be done about symptoms?
Options exist across a wide range, and all of them are conversations for a clinician rather than articles. The 2022 Menopause Society hormone-therapy position statement concluded that hormone therapy remains the most effective treatment for hot flashes and night sweats for appropriate candidates, with individual risk assessment as the deciding factor; nonhormonal medications and low-dose vaginal estrogen serve others. What the evidence does not support, per the same statement, is the unregulated supplement aisle: compounded bioidentical hormones and over-the-counter "hormone-balancing" products lack the safety and efficacy tracking of approved therapies.
When should you talk to a clinician?
Sooner than the culture suggests. The Menopause Society and ACOG guidance point to specific moments: periods so heavy or frequent they affect daily life, symptoms disrupting sleep or work, any bleeding after twelve months without a period, and any uncertainty about what is happening. Heavy bleeding in particular deserves evaluation — it is common in perimenopause and also a symptom that occasionally signals other conditions, which is why guidelines ask that it be assessed rather than endured.
What the evidence establishes is a transition measured in years, driven by fluctuation, with real and treatable symptoms. What remains under-studied — researchers say so plainly — is the experience's variability between people, which no average fully captures.